SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Steffie K. Naber, Inge M. C. M. de Kok, Suzette M. Matthijsse, Marjolein van Ballegooijen, The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study, Cancer Causes & Control, 2016, 27, 4, 569

    CrossRef

  2. 2
    Mario Poljak, Anja Oštrbenk, Katja Seme, Anja Šterbenc, Nina Jančar, Eda Vrtačnik Bokal, Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting, Journal of Clinical Virology, 2016, 76, S29

    CrossRef

  3. 3
    Lawrence von Karsa, Marc Arbyn, Hugo De Vuyst, Joakim Dillner, Lena Dillner, Silvia Franceschi, Julietta Patnick, Guglielmo Ronco, Nereo Segnan, Eero Suonio, Sven Törnberg, Ahti Anttila, European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination, Papillomavirus Research, 2015, 1, 22

    CrossRef

  4. 4
    Vitaly Smelov, K. Miriam Elfström, Anna L.V. Johansson, Carina Eklund, Pontus Naucler, Lisen Arnheim-Dahlström, Joakim Dillner, Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: A 14-year follow-up of a randomized primary HPV screening trial, International Journal of Cancer, 2015, 136, 5
  5. 5
    Joakim Dillner, Prevention of Human Papillomavirus–Associated Cancers, Seminars in Oncology, 2015, 42, 2, 272

    CrossRef

  6. 6
    Margaretha A. Vink, Johannes A. Bogaards, Chris J.L.M. Meijer, Johannes Berkhof, Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?, International Journal of Cancer, 2015, 137, 2
  7. 7
    Andrew J. Coldman, Norm Phillips, Dirk van Niekerk, Laurie Smith, Mel Krajden, Darrel Cook, David J. Quinlan, Thomas Ehlen, Dianne Miller, Gavin C.E. Stuart, Stuart Peacock, Ruth Elwood Martin, Eduardo L. Franco, Gina Ogilvie, Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program, Journal of Obstetrics and Gynaecology Canada, 2015, 37, 5, 412

    CrossRef

  8. 8
    Suzette M. Matthijsse, Jan A.C. Hontelez, Steffie K. Naber, Joost van Rosmalen, Kirsten Rozemeijer, Corine Penning, Roel Bakker, Marjolein van Ballegooijen, Inge M.C.M. de Kok, Sake J. de Vlas, The estimated impact of natural immunity on the effectiveness of human papillomavirus vaccination, Vaccine, 2015, 33, 41, 5357

    CrossRef

  9. 9
    J.A. Louwers, A. Zaal, M. Kocken, J. Berkhof, E. Papagiannakis, P.J.F. Snijders, C.J.L.M. Meijer, R.H.M. Verheijen, The performance of Dynamic Spectral Imaging colposcopy depends on indication for referrals, Gynecologic Oncology, 2015, 139, 3, 452

    CrossRef

  10. 10
    Margot H. Uijterwaal, Nicole J. Polman, Birgit I. Witte, Folkert J. Kemenade, Dorien Rijkaart, Johannes Berkhof, G.A.M.A. Balfoort-van der Meij, Ruediger Ridder, Peter J.F. Snijders, Chris J.L.M. Meijer, Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: Baseline and longitudinal data, International Journal of Cancer, 2015, 136, 10
  11. 11
    Kine Pedersen, Sveinung Wergeland Sørbye, Emily Annika Burger, Stefan Lönnberg, Ivar Sønbø Kristiansen, Using Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal: An Application from the Norwegian Cervical Cancer Screening Program, Value in Health, 2015, 18, 8, 1088

    CrossRef

  12. 12
    M. G. Dijkstra, P. J. F. Snijders, M. Arbyn, D. C. Rijkaart, J. Berkhof, C. J. L. M. Meijer, Cervical cancer screening: on the way to a shift from cytology to full molecular screening, Annals of Oncology, 2014, 25, 5, 927

    CrossRef

  13. 13
    Kate Cuschieri, Heather Cubie, Catriona Graham, Jennifer Rowan, Alison Hardie, Andrew Horne, Camille Busby Earle, Andrew Bailey, Emma J. Crosbie, Henry Kitchener, Clinical performance of RNA and DNA based HPV testing in a colposcopy setting: Influence of assay target, cut off and age, Journal of Clinical Virology, 2014, 59, 2, 104

    CrossRef

  14. 14
    Guglielmo Ronco, Joakim Dillner, K Miriam Elfström, Sara Tunesi, Peter J F Snijders, Marc Arbyn, Henry Kitchener, Nereo Segnan, Clare Gilham, Paolo Giorgi-Rossi, Johannes Berkhof, Julian Peto, Chris J L M Meijer, Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials, The Lancet, 2014, 383, 9916, 524

    CrossRef

  15. 15
    Pierre-Antoine Dugué, Elsebeth Lynge, Matejka Rebolj, Mortality of non-participants in cervical screening: Register-based cohort study, International Journal of Cancer, 2014, 134, 11
  16. 16
    Hung-Cheng Lai, Yu-Che Ou, Tze-Chien Chen, Huei-Jean Huang, Ya-Min Cheng, Chi-Hau Chen, Tang-Yuan Chu, Shih-Tien Hsu, Cheng-Bin Liu, Yao-Ching Hung, Kuo-Chang Wen, Mu-Hsien Yu, Kung-Liahng Wang, PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study, Cancer Medicine, 2014, 3, 4
  17. 17
    Margot H. Uijterwaal, Mariëlle Kocken, Johannes Berkhof, Ruud L.M. Bekkers, Réne H.M. Verheijen, Theo J.M. Helmerhorst, Chris J.L.M. Meijer, Posttreatment Assessment of Women at Risk of Developing High-Grade Cervical Disease, Journal of Lower Genital Tract Disease, 2014, 18, 4, 338

    CrossRef

  18. 18
    J. van der Marel, R. van Baars, A. Rodriguez, W.G.V. Quint, M.M. van de Sandt, J. Berkhof, M. Schiffman, A. Torné, J. Ordi, D. Jenkins, R.H.M. Verheijen, Th.J.M. Helmerhorst, B. ter Harmsel, N. Wentzensen, M. Del Pino, The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy, Gynecologic Oncology, 2014, 135, 2, 201

    CrossRef

  19. 19
    Mariska Bierkens, Albertus T. Hesselink, Chris J.L.M. Meijer, Daniëlle A.M. Heideman, G. Bea A. Wisman, Ate G.J. Zee, Peter J.F. Snijders, Renske D.M. Steenbergen, CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease, International Journal of Cancer, 2013, 133, 6
  20. 20
    Michael H. Chung, Kevin P. McKenzie, Hugo De Vuyst, Barbra A. Richardson, Farzana Rana, Ritesh Pamnani, Julia W. Njoroge, Evans Nyongesa-Malava, Samah R. Sakr, Grace C. John-Stewart, Nelly R. Mugo, Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy, AIDS, 2013, 27, 18, 2909

    CrossRef

  21. 21
    Dean A. Regier, Kim van der Hoek, Gina Ogilvie, Laurie Smith, Elena Henwood, Dianne M. Miller, Helen McTaggart-Cowan, Stuart J. Peacock, Exploring Colposcopists' Attitudes Towards Use of HPV Testing as a Primary Screening Tool for Cervical Cancer in British Columbia, Journal of Obstetrics and Gynaecology Canada, 2013, 35, 7, 657

    CrossRef

  22. 22
    Roderick E. Bruijn, Danielle A.M. Heideman, Gemma G. Kenter, Marc Beurden, Harm Tinteren, Simon Horenblas, Patients with penile cancer and the risk of (pre)malignant cervical lesions in female partners: a retrospective cohort analysis, BJU International, 2013, 112, 7
  23. 23
    Jae Kwan Lee, Jin Hwa Hong, Sokbom Kang, Dae-Yeon Kim, Byoung-Gie Kim, Sung-Hoon Kim, Yong-Man Kim, Jae-Weon Kim, Jae-Hoon Kim, Tae-Jin Kim, Hyun Jung Kim, Hye Sun Kim, Hee-Sug Ryu, Jae Yun Song, Hyeong Sik Ahn, Chong Woo Yoo, Hye-Kyoung Yoon, Keun-Ho Lee, Ahwon Lee, Yonghee Lee, In Ho Lee, Jeong-Won Lee, Taek Sang Lee, Myong Cheol Lim, Suk-Joon Chang, Hyun Hoon Chung, Woong Ju, Hee Jae Joo, Soo-Young Hur, Sung-Ran Hong, Joo-Hyun Nam, Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition, Journal of Gynecologic Oncology, 2013, 24, 2, 186

    CrossRef

  24. 24
    Jennifer A. Brainard, George G. Birdsong, Tarik M. Elsheikh, David A. Hartley, Kalyani Naik, Margaret H. Neal, Rhona J. Souers, Michael R. Henry, Prospective and Retrospective Review of Gynecologic Cytopathology: Findings From the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference Working Group 2, Archives of Pathology & Laboratory Medicine, 2013, 137, 2, 175

    CrossRef

  25. 25
    Sonya J. Hwang, Kenneth R. Shroyer, Biomarkers of Cervical Dysplasia and Carcinoma, Journal of Oncology, 2012, 2012, 1

    CrossRef

  26. 26
    Ágnes Lendvai, Frank Johannes, Christina Grimm, Jasper J.H. Eijsink, René Wardenaar, Haukeline H. Volders, Harry G. Klip, Harry Hollema, Ritsert C. Jansen, Ed Schuuring, G. Bea A. Wisman, Ate G.J. van der Zee, Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia, Epigenetics, 2012, 7, 11, 1268

    CrossRef

  27. 27
    J.A. Louwers, J. Berkhof, A. Zaal, M. Kocken, L. Rozendaal, D.A.M. Heideman, W.M. van Baal, P.J.F. Snijders, R.H.M. Verheijen, C.J.L.M. Meijer, HrHPV-testing in a university hospital gynecology outpatient clinic: Recommendations for clinical practice, Gynecologic Oncology, 2012, 124, 3, 518

    CrossRef

  28. 28
    Dorien C Rijkaart, Johannes Berkhof, Lawrence Rozendaal, Folkert J van Kemenade, Nicole WJ Bulkmans, Daniëlle AM Heideman, Gemma G Kenter, Jack Cuzick, Peter JF Snijders, Chris JLM Meijer, Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial, The Lancet Oncology, 2012, 13, 1, 78

    CrossRef

  29. 29
    M Kocken, J Berkhof, F J van Kemenade, J A Louwers, A Zaal, M A E Nobbenhuis, G Kenter, P J F Snijders, C J L M Meijer, T J M Helmerhorst, Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing, British Journal of Cancer, 2012, 106, 5, 817

    CrossRef

  30. 30
    Renée M. Overmeer, Jacqueline A. Louwers, Chris J.L.M. Meijer, Folkert J. van Kemenade, Albertus T. Hesselink, Nathalie Fransen Daalmeijer, Saskia M. Wilting, Daniëlle A.M. Heideman, René H.M. Verheijen, Afra Zaal, W. Marchien van Baal, Johannes Berkhof, Peter J.F. Snijders, Renske D.M. Steenbergen, Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women, International Journal of Cancer, 2011, 129, 9
  31. 31
    Joseph E. Tota, Myriam Chevarie-Davis, Lyndsay A. Richardson, Maaike deVries, Eduardo L. Franco, Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies, Preventive Medicine, 2011, 53, S12

    CrossRef

  32. 32
    Serge J. Smeets, Marlon van der Plas, Tieneke B.M. Schaaij-Visser, Eva A.M. van Veen, Johan van Meerloo, Boudewijn J.M. Braakhuis, Renske D.M. Steenbergen, Ruud H. Brakenhoff, Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways, International Journal of Cancer, 2011, 128, 7
  33. 33
    Maribel Almonte, Peter Sasieni, Jack Cuzick, Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines, Best Practice & Research Clinical Obstetrics & Gynaecology, 2011, 25, 5, 617

    CrossRef

  34. 34
    Roosmarie P. de Bie, Henke C. Vergers-Spooren, Leon F.A.G. Massuger, Albertus G. Siebers, Maria R.J. Salet-van der Pol, Judith E.M. Vedder, Willem J.G. Melchers, Johan Bulten, Ruud L.M. Bekkers, Patients with cervical cancer: why did screening not prevent these cases?, American Journal of Obstetrics and Gynecology, 2011, 205, 1, 64.e1

    CrossRef

  35. 35
    W.F. van der Meide, S. Snellenberg, C.J.L.M. Meijer, A. Baalbergen, T.J.M. Helmerhorst, W.B. van der Sluis, P.J.F. Snijders, R.D.M. Steenbergen, Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix, Gynecologic Oncology, 2011, 123, 1, 116

    CrossRef

  36. 36
    Roosmarie P. de Bie, Channa E. Schmeink, Judith M.J.E. Bakkers, Peter J.F. Snijders, Wim G.V. Quint, Leon F.A.G. Massuger, Ruud L.M. Bekkers, Willem J.G. Melchers, The Indicating FTA Elute Cartridge, The Journal of Molecular Diagnostics, 2011, 13, 4, 371

    CrossRef

  37. 37
    Channa E. Schmeink, Ruud L. M. Bekkers, Leon F. A. G. Massuger, Willem J. G. Melchers, The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening, Reviews in Medical Virology, 2011, 21, 3
  38. 38
    ROOSMARIE P. DE BIE, LEON F.A.G. MASSUGER, ROEL A.J.M. VAN DONGEN, MARC P.M.L. SNIJDERS, JOHAN BULTEN, WILLEM J.G. MELCHERS, RUUD L.M. BEKKERS, To treat or not to treat; the clinical dilemma of atypical squamous cells of undetermined significance (ASC-US), Acta Obstetricia et Gynecologica Scandinavica, 2011, 90, 4
  39. 39
    D.T. Geraets, C.H. Lenselink, R.L.M. Bekkers, L.J. van Doorn, W.G.V. Quint, W.J.G. Melchers, Universal human papillomavirus genotyping by the digene HPV Genotyping RH and LQ Tests, Journal of Clinical Virology, 2011, 50, 4, 276

    CrossRef

  40. 40
    Daniel Summerer, Dona Hevroni, Amit Jain, Olga Oldenburger, Jefferson Parker, Anthony Caruso, Cord F. Stähler, Peer F. Stähler, Markus Beier, A flexible and fully integrated system for amplification, detection and genotyping of genomic DNA targets based on microfluidic oligonucleotide arrays, New Biotechnology, 2010, 27, 2, 149

    CrossRef

  41. 41
    Jacqueline A. Louwers, Mariëlle Kocken, Joyce C. van der Bijl, Johannes Berkhof, Peter J.F. Snijders, Chris J.L.M. Meijer, René H.M. Verheijen, Colposcopic Characteristics of High-Risk Human Papillomavirus-Related Cervical Lesions, Journal of Lower Genital Tract Disease, 2010, 14, 1, 49

    CrossRef

  42. 42
    J. A. Bogaards, M. Xiridou, V. M. H. Coupe, C. J. L. M. Meijer, J. Wallinga, J. Berkhof, Model-Based Estimation of Viral Transmissibility and Infection-Induced Resistance From the Age-Dependent Prevalence of Infection for 14 High-Risk Types of Human Papillomavirus, American Journal of Epidemiology, 2010, 171, 7, 817

    CrossRef

  43. 43
    Joseph Tota, Salaheddin M. Mahmud, Alex Ferenczy, François Coutlée, Eduardo L. Franco, Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era, Sexual Health, 2010, 7, 3, 376

    CrossRef

  44. 44
    Hung-Cheng Lai, Ya-Wen Lin, Rui-Lan Huang, Ming-Tzeung Chung, Hui-Chen Wang, Yu-Ping Liao, Po-Hsuan Su, Yung-Liang Liu, Mu-Hsien Yu, Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse, Cancer, 2010, 116, 18
  45. 45
    Philippe Halfon, Dominique Benmoura, Aubert Agostini, Hacene Khiri, Agnés Martineau, Guillaume Penaranda, Bernard Blanc, Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ® HPV assay, Journal of Clinical Virology, 2010, 47, 2, 177

    CrossRef

  46. 46
    Johannes Berkhof, Veerle M. Coupé, Johannes A. Bogaards, Folkert J. van Kemenade, Theo J. Helmerhorst, Peter J. Snijders, Chris J. Meijer, The health and economic effects of HPV DNA screening in The Netherlands, International Journal of Cancer, 2010, 127, 9
  47. 47
    Johannes Berkhof, Johannes A Bogaards, Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer, Future Oncology, 2010, 6, 12, 1817

    CrossRef

  48. 48
    M. Leinonen, P. Nieminen, L. Kotaniemi-Talonen, N. Malila, J. Tarkkanen, P. Laurila, A. Anttila, Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting, JNCI Journal of the National Cancer Institute, 2009, 101, 23, 1612

    CrossRef

  49. 49
    D. Riethmuller, Dépistage du cancer du col de l’utérus : restaurer ou reconstruire ?, Gynécologie Obstétrique & Fertilité, 2009, 37, 7-8, 671

    CrossRef

  50. 50
    P. Naucler, W. Ryd, S. Tornberg, A. Strand, G. Wadell, K. Elfgren, T. Radberg, B. Strander, O. Forslund, B.-G. Hansson, B. Hagmar, B. Johansson, E. Rylander, J. Dillner, Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening, JNCI Journal of the National Cancer Institute, 2009, 101, 2, 88

    CrossRef

  51. 51
    Albertus T. Hesselink, Johannes Berkhof, Daniëlle A.M. Heideman, Nicole W.J. Bulkmans, Jurjen E.H. van Tellingen, Chris J.L.M. Meijer, Peter J.F. Snijders, High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer, International Journal of Cancer, 2009, 124, 2
  52. 52
    Aagje G. Bais, Marinus J.C. Eijkemans, Mateja Rebolj, Peter J.F. Snijders, René H.M. Verheijen, Marjolein van Ballegooijen, Chris J.L.M. Meijer, Theo J.M. Helmerhorst, Post-treatment CIN: Randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease, International Journal of Cancer, 2009, 124, 4
  53. 53
    S. Gupta, P. Sodhani, A. Sharma, J. K. Sharma, K. Halder, K. L. Charchra, S. Sardana, V. Singh, A. Sehgal, B. C. Das, Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis, Cytopathology, 2009, 20, 4
  54. 54
    Elsebeth Lynge, Matejka Rebolj, Primary HPV screening for cervical cancer prevention: results from European trials, Nature Reviews Clinical Oncology, 2009, 6, 12, 699

    CrossRef

  55. 55
    Martina Schmitz, Cornelia Scheungraber, Jörg Herrmann, Karin Teller, Mieczyslaw Gajda, Ingo B. Runnebaum, Matthias Dürst, Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types, Journal of Clinical Virology, 2009, 44, 4, 302

    CrossRef

  56. 56
    Renée M Overmeer, Florianne E Henken, Mariska Bierkens, Saskia M Wilting, Ilse Timmerman, Chris JLM Meijer, Peter JF Snijders, Renske DM Steenbergen, Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis, The Journal of Pathology, 2009, 219, 3
  57. 57
    V M H Coupé, J Berkhof, N W J Bulkmans, P J F Snijders, C J L M Meijer, Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening, British Journal of Cancer, 2008, 98, 3, 646

    CrossRef

  58. 58
    Jennifer S. Smith, Amy Melendy, Rashida K. Rana, Jeanne M. Pimenta, Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review, Journal of Adolescent Health, 2008, 43, 4, S5.e1

    CrossRef

  59. 59
    RM Overmeer, FE Henken, PJF Snijders, D Claassen-Kramer, J Berkhof, TJM Helmerhorst, DAM Heideman, SM Wilting, Y Murakami, A Ito, CJLM Meijer, RDM Steenbergen, Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC, The Journal of Pathology, 2008, 215, 4
  60. 60
    Eduardo L. Franco, Jack Cuzick, Cervical cancer screening following prophylactic human papillomavirus vaccination, Vaccine, 2008, 26, A16

    CrossRef

  61. 61
    Angel Chao, Kuang-Hung Hsu, Chyong-Huey Lai, Huei-Jean Huang, Swei Hsueh, Sheue-Rong Lin, Shih-Ming Jung, Fang-Yu Chao, Shang-Lang Huang, Chu-Chun Huang, Jung-Erh Yang, Ting-Chang Chang, Cervical cancer screening program integrating Pap smear and HPV DNA testing: A population-based study, International Journal of Cancer, 2008, 122, 12
  62. 62
    H. J. T. van Zeeburg, P. J. F. Snijders, T. Wu, E. Gluckman, J. Soulier, J. Surralles, M. Castella, J. E. van der Wal, J. Wennerberg, J. Califano, E. Velleuer, R. Dietrich, W. Ebell, E. Bloemena, H. Joenje, C. R. Leemans, R. H. Brakenhoff, Clinical and Molecular Characteristics of Squamous Cell Carcinomas From Fanconi Anemia Patients, JNCI Journal of the National Cancer Institute, 2008, 100, 22, 1649

    CrossRef

  63. 63
    L.Z. Mo, S. Monnier-Benoit, B. Kantelip, A. Petitjean, D. Riethmuller, J.L. Prétet, C. Mougin, Comparison of AMPLICOR® and Hybrid Capture II® assays for high risk HPV detection in normal and abnormal liquid-based cytology: Use of INNO-LiPA Genotyping assay to screen the discordant results, Journal of Clinical Virology, 2008, 41, 2, 104

    CrossRef

  64. 64
    A Kathrine Lie, Gunnar Kristensen, Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma, Expert Review of Molecular Diagnostics, 2008, 8, 4, 405

    CrossRef

  65. 65
    Magdalena Grce, Philip Davies, Human papillomavirus testing for primary cervical cancer screening, Expert Review of Molecular Diagnostics, 2008, 8, 5, 599

    CrossRef

  66. 66
    Lynn J. Shepherd, S.C. Peter Bryson, Human Papillomavirus—Lessons From History and Challenges for the Future, Journal of Obstetrics and Gynaecology Canada, 2008, 30, 11, 1025

    CrossRef

  67. 67
    Hung-Cheng Lai, Ya-Wen Lin, Tim H.M. Huang, Pearlly Yan, Rui-Lan Huang, Hui-Chen Wang, Joseph Liu, Michael W.Y. Chan, Tang-Yuan Chu, Chien-An Sun, Cheng-Chang Chang, Mu-Hsien Yu, Identification of novel DNA methylation markers in cervical cancer, International Journal of Cancer, 2008, 123, 1
  68. 68
    D. Riethmuller, R. Ramanah, J.-L. Pretet, C. Mougin, Intégration du test HPV dans le dépistage primaire ?, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2008, 37, 1, S139

    CrossRef

  69. 69
    Y-K Huang, S-L You, C-C Yuan, Y-M Ke, J-M Cao, C-Y Liao, C-H Wu, C-S Hsu, K-F Huang, C-H Lu, N-F Twu, T-Y Chu, Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening, British Journal of Cancer, 2008, 98, 5, 863

    CrossRef

  70. 70
    Raina M. Rogoza, Nicole Ferko, James Bentley, Chris J.L.M. Meijer, Johannes Berkhof, Kung-Liahng Wang, Levi Downs, Jennifer S. Smith, Eduardo L. Franco, Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: A multi-regional health economic analysis, Vaccine, 2008, 26, F46

    CrossRef

  71. 71
    Maarit Leinonen, Laura Kotaniemi-Talonen, Ahti Anttila, Tadeusz Dyba, Jussi Tarkkanen, Pekka Nieminen, Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland, International Journal of Cancer, 2008, 123, 6
  72. 72
    Laura Kotaniemi-Talonen, Ahti Anttila, Nea Malila, Jussi Tarkkanen, Pekka Laurila, Matti Hakama, Pekka Nieminen, Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3, European Journal of Cancer, 2008, 44, 4, 565

    CrossRef

  73. 73
    Christine Clavel, Véronique Dalstein, Philippe Birembaut, Stratégies de dépistage des lésions précancéreuses du col de l’utérus : cytologie ou test HPV ?, Revue Francophone des Laboratoires, 2008, 2008, 405, 57

    CrossRef

  74. 74
    DAM Heideman, PJF Snijders, J Berkhof, RHM Verheijen, TJM Helmerhorst, CJLM Meijer, Vaccination against HPV: indications for women and the impact on the cervical screening programme, BJOG: An International Journal of Obstetrics & Gynaecology, 2008, 115, 8
  75. 75
    Hein J. Boot, Iris Wallenburg, Hester E. de Melker, Marie-José M. Mangen, Annette A.M. Gerritsen, Nicoline A. van der Maas, Johannes Berkhof, Chris J.L.M. Meijer, Tjeerd G. Kimman, Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands, Vaccine, 2007, 25, 33, 6245

    CrossRef

  76. 76
    CFM Prinsen, R Fles, CW Wijnen-Dubbers, HA De Valk, CHW Klaassen, M Mravunac, AM Horrevorts, FBJM Thunnissen, Baseline human papillomavirus status of women with abnormal smears in cervical screening: a 5-year follow-up study in the Netherlands, BJOG: An International Journal of Obstetrics & Gynaecology, 2007, 114, 8
  77. 77
    Sanjay Gupta, Veena Singh, Ashok Sehgal, Pushpa Sodhani, Cervical cancer in resource-limited settings: preventable but not yet prevented, Expert Review of Obstetrics & Gynecology, 2007, 2, 4, 515

    CrossRef

  78. 78
    Eduardo L Franco, Alex Ferenczy, Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination, Future Oncology, 2007, 3, 3, 319

    CrossRef

  79. 79
    VMH Coupé, J Berkhof, RHM Verheijen, CJLM Meijer, Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia, BJOG: An International Journal of Obstetrics & Gynaecology, 2007, 114, 4
  80. 80
    J. Visser, H. W. Nijman, B.-N. Hoogenboom, P. Jager, D. Van Baarle, E. Schuuring, W. Abdulahad, F. Miedema, A. G. Van Der Zee, T. Daemen, Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia, Clinical & Experimental Immunology, 2007, 150, 2
  81. 81
    N W J Bulkmans, J Berkhof, S Bulk, M C G Bleeker, F J van Kemenade, L Rozendaal, P J F Snijders, C J L M Meijer, High-risk HPV type-specific clearance rates in cervical screening, British Journal of Cancer, 2007,

    CrossRef

  82. 82
    Pontus Naucler, Walter Ryd, Sven Törnberg, Anders Strand, Göran Wadell, Kristina Elfgren, Thomas Rådberg, Björn Strander, Bo Johansson, Ola Forslund, Bengt-Göran Hansson, Eva Rylander, Joakim Dillner, Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer, New England Journal of Medicine, 2007, 357, 16, 1589

    CrossRef

  83. 83
    NWJ Bulkmans, J Berkhof, L Rozendaal, FJ van Kemenade, AJP Boeke, S Bulk, FJ Voorhorst, RHM Verheijen, K van Groningen, ME Boon, W Ruitinga, M van Ballegooijen, PJF Snijders, CJLM Meijer, Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial, The Lancet, 2007, 370, 9601, 1764

    CrossRef

  84. 84
    Chyong-Huey Lai, Huei-Jean Huang, Swei Hsueh, Angel Chao, Cheng-Tao Lin, Shang-Lang Huang, Fang-Yu Chao, Jian-Tai Qiu, Ji-Hong Hong, Hung-Hsueh Chou, Ting-Chang Chang, Chee-Jen Chang, Human papillomavirus genotype in cervical cancer: A population-based study, International Journal of Cancer, 2007, 120, 9
  85. 85
    Aagje G. Bais, Folkert J. van Kemenade, Johannes Berkhof, René H.M. Verheijen, Peter J.F. Snijders, Feja Voorhorst, Milena Babović, Marjolein van Ballegooijen, Theo J.M. Helmerhorst, Chris J.L.M. Meijer, Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs, International Journal of Cancer, 2007, 120, 7
  86. 86
    Matejka Rebolj, Aagje G. Bais, Marjolein van Ballegooijen, Rob Boer, Willem-Jan Meerding, Theo J.M. Helmerhorst, J. Dik F. Habbema, Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies, International Journal of Cancer, 2007, 121, 7
  87. 87
    A. G. Siebers, L. F. A. G. Massuger, J. Bulten, Referral compliance, outcome and predictors of CIN after repeated borderline cervical smears in the Netherlands, Cytopathology, 2007, 18, 2
  88. 88
    Saskia Bulk, Nicole W.J. Bulkmans, Johannes Berkhof, Lawrence Rozendaal, A. Joan P. Boeke, René H.M. Verheijen, Peter J.F. Snijders, Chris J.L.M. Meijer, Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months, International Journal of Cancer, 2007, 121, 2
  89. 89
    W. Gray, E. Bayer-Pietsch, P. Chieco, B. Cochand Priollet, M. Desai, M. Drijkoningen, M. Griffin, B. Hagmar, K. Kapila, V. Kloboves-Prevodnik, T. Kobayashi, L. Krogerus, B. Majak, M. Mihailovici, W. Olszewski, U. Schenck, F. Schmitt, I. Shabalova, N. Shapiro, J. Smith, E. Tani, M. Totsch, L. Vass, H. Wiener, A. Herbert, The future of cytopathology in Europe. Will the wider use of HPV testing have an impact on the provision of cervical screening?, Cytopathology, 2007, 18, 5
  90. 90
    Philip Davies, Marc Arbyn, Joakim Dillner, Henry C. Kitchener, Chris J.L.M. Meijer, Guglielmo Ronco, Matti Hakama, A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening, International Journal of Cancer, 2006, 118, 4
  91. 91
    Dorien C. Rijkaart, Tj. Romke Bontekoe, Hans Korporaal, Mathilde E. Boon, Alternating high-risk human papillomavirus infection, Cancer Cytopathology, 2006, 108, 6
  92. 92
    Luiz Carlos Zeferino, Sophie Françoise Derchain, Cervical cancer in the developing world, Best Practice & Research Clinical Obstetrics & Gynaecology, 2006, 20, 3, 339

    CrossRef

  93. 93
    Peter J.F. Snijders, Cornelis J.A. Hogewoning, Albertus T. Hesselink, Johannes Berkhof, Feja J. Voorhorst, Maaike C.G. Bleeker, Chris J.L.M. Meijer, Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology, International Journal of Cancer, 2006, 119, 5
  94. 94
    R.L.M Bekkers, C.J.L.M. Meijer, L.F.A.G. Massuger, P.J.F. Snijders, W.J.G Melchers, Effects of HPV detection in population-based screening programmes for cervical cancer; a Dutch moment, Gynecologic Oncology, 2006, 100, 3, 451

    CrossRef

  95. 95
    Jeroen Visser, Debbie van Baarle, Baukje Nynke Hoogeboom, Nathalie Reesink, Harry Klip, Ed Schuuring, Esther Nijhuis, Michael Pawlita, Laura Bungener, Jacqueline de Vries-Idema, Hans Nijman, Frank Miedema, Toos Daemen, Ate van der Zee, Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia, International Journal of Cancer, 2006, 118, 10
  96. 96
    Johannes Berkhof, Martine C. de Bruijne, Gilda D. Zielinski, Nicole W.J. Bulkmans, Lawrence Rozendaal, Peter J.F. Snijders, René H.M. Verheijen, Chris J.L.M. Meijer, Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis, International Journal of Cancer, 2006, 118, 7
  97. 97
    Tom Cox, Jack Cuzick, HPV DNA testing in cervical cancer screening: From evidence to policies, Gynecologic Oncology, 2006, 103, 1, 8

    CrossRef

  98. 98
    Antoinette A.T.P. Brink, Peter J.F. Snijders, Chris J.L.M. Meijer, Johannes Berkhof, René H.M. Verheijen, HPV testing in cervical screening, Best Practice & Research Clinical Obstetrics & Gynaecology, 2006, 20, 2, 253

    CrossRef

  99. You have free access to this content99
    Peter JF Snijders, Renske DM Steenbergen, Daniëlle AM Heideman, Chris JLM Meijer, HPV-mediated cervical carcinogenesis: concepts and clinical implications, The Journal of Pathology, 2006, 208, 2
  100. 100
    A. LONGATTO-FILHO, M. ERŽEN, M. BRANCA, C. ROTELI-MARTINS, P. NAUD, S.F.M. DERCHAIN, L. HAMMES, L.O. SARIAN, J.F. BRAGANÇA, J. MATOS, R. GONTIJO, T. LIMA, M.Y.S. MAEDA, S. TATTI, S. SYRJÄNEN, G. DORES, A. LÖRINCZ, K. SYRJÄNEN, Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study, International Journal of Gynecological Cancer, 2006, 16, 3
  101. 101
    Eduardo L Franco, Alex Ferenczy, Is HPV testing with cytological triage a more logical approach in cervical cancer screening?, The Lancet Oncology, 2006, 7, 7, 527

    CrossRef

  102. 102
    Servi J.C. Stevens, Sandra A.W.M. Verkuijlen, Bambang Hariwiyanto, Harijadi, Dewi K. Paramita, Jajah Fachiroh, Marlinda Adham, I. Bing Tan, Sophia M. Haryana, Jaap M. Middeldorp, Noninvasive diagnosis of nasopharyngeal carcinoma: Nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA, International Journal of Cancer, 2006, 119, 3
  103. 103
    Jack Cuzick, Christine Clavel, Karl-Ulrich Petry, Chris J.L.M. Meijer, Heike Hoyer, Samuel Ratnam, Anne Szarewski, Philippe Birembaut, Shalini Kulasingam, Peter Sasieni, Thomas Iftner, Overview of the European and North American studies on HPV testing in primary cervical cancer screening, International Journal of Cancer, 2006, 119, 5
  104. 104
    S Bulk, J Berkhof, N W J Bulkmans, G D Zielinski, L Rozendaal, F J van Kemenade, P J F Snijders, C J L M Meijer, Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands, British Journal of Cancer, 2006, 94, 1, 171

    CrossRef

  105. 105
    Elaine Bentley, Seonaidh C Cotton, Margaret E Cruickshank, Ian Duncan, Nicola M Gray, David Jenkins, Julian Little, Keith Neal, Zo?? Philips, Ian Russell, Rashmi Seth, Linda Sharp, Norman Waugh, Refining the Management of Low-Grade Cervical Abnormalities in the UK National Health Service and Defining the Potential for Human Papillomavirus Testing: A Commentary on Emerging Evidence, Journal of Lower Genital Tract Disease, 2006, 10, 1, 26

    CrossRef

  106. 106
    Seonaidh C. Cotton, Linda Sharp, Julian Little, Ian Duncan, Lindyanne Alexander, Margaret E. Cruickshank, Nicola M. Gray, David Jenkins, Zoë Philips, Alistair Robertson, Rashmi Seth, Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): Trial design, Contemporary Clinical Trials, 2006, 27, 5, 449

    CrossRef

  107. 107
    A. A. T. P. Brink, G. D. Zielinski, R. D. M. Steenbergen, P. J. F. Snijders, C. J. L. M. Meijer, Clinical relevance of human papillomavirus testing in cytopathology, Cytopathology, 2005, 16, 1
  108. 108
    Maaike C.G. Bleeker, Cornelis J.A. Hogewoning, Feja J. Voorhorst, Adriaan J.C. van den Brule, Johannes Berkhof, Albertus T. Hesselink, Marjolein Lettink, Theo M. Starink, Tom J. Stoof, Peter J.F. Snijders, Chris J.L.M. Meijer, HPV-associated flat penile lesions in men of a non-STD hospital population: Less frequent and smaller in size than in male sexual partners of women with CIN, International Journal of Cancer, 2005, 113, 1
  109. 109
    S Franceschi, C Mahé, Human papillomavirus testing in cervical cancer screening, British Journal of Cancer, 2005, 92, 9, 1591

    CrossRef

  110. 110
    John Doorbar, Heather Cubie, Molecular Basis for Advances in Cervical Screening, Molecular Diagnosis, 2005, 9, 3, 129

    CrossRef

  111. 111
    John Doorbar, Heather Cubie, Molecular Basis for Advances in Cervical Screening, Molecular Diagnosis, 2005, 9, 3, 129

    CrossRef

  112. 112
    Johannes Berkhof, Martine C de Bruijne, Gilda D Zielinski, Chris JLM Meijer, Natural history and screening model for high-risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands, International Journal of Cancer, 2005, 115, 2
  113. 113
    Michael Dray, Peter Russell, Chris Dalrymple, Neil Wallman, george Angus, Adelyn Leong, Jonathan Carter, Bharathi Cheerala, p16iNK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies, Pathology, 2005, 37, 2, 112

    CrossRef

  114. 114
    Joseph Monsonego, Jean Marc Bohbot, Giuseppe Pollini, Claude Krawec, Catherine Vincent, Isabelle Merignargues, Fatima Haroun, Patrice Sednaoui, Laura Monfort, Roger Dachez, Kari Syrjänen, Performance of the Roche AMPLICOR® Human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear, Gynecologic Oncology, 2005, 99, 1, 160

    CrossRef

  115. 115
    Raksha Arora, Arunaz Kumar, Bhupesh K. Prusty, Uma Kailash, Swaraj Batra, Bhudev C. Das, Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2005, 121, 1, 104

    CrossRef

  116. 116
    Nicole W.J. Bulkmans, Maaike C.G. Bleeker, Johannes Berkhof, Feja J. Voorhorst, Peter J.F. Snijders, Chris J.L.M. Meijer, Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse, International Journal of Cancer, 2005, 117, 2
  117. 117
    L Kotaniemi-Talonen, P Nieminen, A Anttila, M Hakama, Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting, British Journal of Cancer, 2005, 93, 8, 862

    CrossRef

  118. 118
    M. S. Desai, Heather A. Cubie, The HPV test in cervical screening: a brave new world?, Cytopathology, 2005, 16, 1
  119. 119
    Kate S. Cuschieri, Heather A. Cubie, The role of human papillomavirus testing in cervical screening, Journal of Clinical Virology, 2005, 32, 34

    CrossRef

  120. 120
    Aagje G. Bais, Matejka Rebolj, Peter J.F. Snijders, Frits A. de Schipper, Dries A.J. van der Meulen, René H.M. Verheijen, Feja Voorhorst, Marjolein van Ballegooijen, Chris J.L.M. Meijer, Theo J.M. Helmerhorst, Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: Proposal for new guidelines, International Journal of Cancer, 2005, 116, 1
  121. 121
    Eduardo L. Franco, Randomized controlled trials of HPV testing and pap cytology: Toward evidence-based cervical cancer prevention, International Journal of Cancer, 2004, 110, 1